mortality/aging
embryo
• growth arrest at E8.0 after gastrulation but prior to establishment of circulation
|
Allele Symbol Allele Name Allele ID |
Pdcd10tm1.1Kwhi targeted mutation 1.1, Kevin Whitehead MGI:5052184 |
||||||||||||
Summary |
2 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• growth arrest at E8.0 after gastrulation but prior to establishment of circulation
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• increased early mortality
|
• cerebral cavernous malformations develop by one month after tamoxifen treatment at 1 day of age
• additional abnormalities include capillary telangiectasias, isolated caverns and multiple back to back caverns, thrombosis, hemorrhage, formation of secondary channels
• attenuation of endothelial cells in larger secondary channels but no gaps
|
• foot processes are missing
|
• cerebral cavernous malformations develop by one month after tamoxifen treatment at 1 day of age
• additional abnormalities include capillary telangiectasias, isolated caverns and multiple back to back caverns, thrombosis, hemorrhage, formation of secondary channels
• attenuation of endothelial cells in larger secondary channels but no gaps
|
• foci of mononuclear inflammatory cells also seen
|
• foot processes are missing
|
• foci of mononuclear inflammatory cells also seen
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
cerebral cavernous malformation 3 | DOID:0060671 |
OMIM:603285 |
J:173947 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
![]() |
|